Found: 10
Select item for more details and to access through your institution.
Biomarker MET in der Tumorpathologie.
- Published in:
- Die Pathologie, 2023, v. 44, n. 3, p. 193, doi. 10.1007/s00292-023-01189-2
- By:
- Publication type:
- Article
Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104566
- By:
- Publication type:
- Article
Overview of Molecular Detection Technologies for MET in Lung Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2932, doi. 10.3390/cancers15112932
- By:
- Publication type:
- Article
HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.
- Published in:
- Journal of Pathology: Clinical Research, 2016, v. 2, n. 2, p. 59, doi. 10.1002/cjp2.35
- By:
- Publication type:
- Article
Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1311-0
- By:
- Publication type:
- Article
Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0193048
- By:
- Publication type:
- Article
miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 7, p. 1421, doi. 10.1016/j.molonc.2015.03.013
- By:
- Publication type:
- Article
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-13
- By:
- Publication type:
- Article
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.
- Published in:
- 2014
- By:
- Publication type:
- journal article